Undoubtedly, the effect of ADAs in MPS is more difficult to evaluate than in infantile Pompe disease due to the slowly progressive course of MPS and the fact that no consistent relationship between ADA titre and clinical outcome has been documented until now. Here, AGPS is linked to mucopolysaccharidosis.